Table 2.

Summary of adverse events

	Netarsudil/latanoprost FDC n = 482	Netarsudil n = 498	Latanoprost n = 488
AEs, n	1266	1190	540
Ocular AEs, n	1121	1033	336
Non-ocular AEs, n	145	157	204
Serious AEs, n	9	19	19
Treatment-related AEs, n	931	836	243
Treatment-related serious AEs, n	0	0	0
AEs by maximum severity, n (%)
Mild	280 (58.1)	267 (53.6)	187 (38.3)
Moderate	75 (15.6)	68 (13.7)	42 (8.6)
Severe	13 (2.7)	16 (3.2)	8 (1.6)

Percentages are based on the number of patients (n) in a given treatment group for the safety population

AE treatment emergent adverse event